# Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease

> **NCT05269173** · PHASE2 · COMPLETED · sponsor: **Capital Medical University** · enrollment: 240 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Flos gossypii flavonoids tablet

## Key facts

- **NCT ID:** NCT05269173
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2024-08-13
- **Final completion:** 2024-11-05
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269173, "Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05269173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*